Lungex II

Wirkstoff: GINKGO, SUS SCROFA COLON, SUS SCROFA LUNG, SUS SCROFA PANCREAS, GERMANIUM SESQUIOXIDE, COPPER, MANGANESE, TIN, OXOGLURIC ACID, CITRIC ACID MONOHYDRATE, FUMARIC ACID, MALIC ACID, PYRUVIC ACID, SUCCINIC ACID, 1,2-NAPHTHOQUINONE, ARSENIC, OYSTER SHELL CALCIUM CARBONATE, CRUDE, ACONITIC ACID, SODIUM DIETHYL OXALACETATE, PHOSPHORUS

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · GINKGO 6 [hp_X]/mL, SUS SCROFA COLON 6 [hp_X]/mL, SUS SCROFA LUNG 6 [hp_X]/mL, SUS SCROFA PANCREAS 6 [hp_X]/mL, GERMANIUM SESQUIOXIDE 8 [hp_X]/mL, COPPER 8 [hp_X]/mL, MANGANESE 8 [hp_X]/mL, TIN 8 [hp_X]/mL, OXOGLURIC ACID 8 [hp_X]/mL, CITRIC ACID MONOHYDRATE 8 [hp_X]/mL, FUMARIC ACID 8 [hp_X]/mL, MALIC ACID 8 [hp_X]/mL, PYRUVIC ACID 8 [hp_X]/mL, SUCCINIC ACID 8 [hp_X]/mL, 1,2-NAPHTHOQUINONE 9 [hp_X]/mL, ARSENIC 12 [hp_X]/mL, OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/mL, ACONITIC ACID 12 [hp_X]/mL, SODIUM DIETHYL OXALACETATE 12 [hp_X]/mL, PHOSPHORUS 12 [hp_X]/mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: Energique, Inc.

Geprüft 2026-10-09 · openFDA NDC